Bilcare GCS Opens New Global U.S. Headquarters

Bilcare GCS Opens New Global U.S. Headquarters

San Francisco, CA – July 31, 2008 - Bilcare Global Clinical Supplies, a
leading single-source provider of clinical trial services, announced that it
has opened its new global U.S. headquarters in San Francisco. The
headquarters, which will be led by CEO Vito Mangiardi, operates as the
company’s corporate hub to drive growth in Bilcare’s American, European, and
Asian regions.

“This year has been one of substantial growth in every area of our global
business, from staffing and facilities to equipment and services,” said
Mangiardi. “While our U.S., India, and Wales-based facilities manage the
increased demand for research and packaging services, our headquarters will
dedicate itself to furthering global integration and growing the company as
a full-service solutions provider that can take customers from research and
development, to Phase I and II trials, and through longer-term Phase III
trials.”

The opening of Bilcare GCS’ global headquarters marks the latest development
in the company’s significant growth. During its 2007-2008 fiscal year,
Bilcare GCS nearly doubled its global workforce, including significant
additions to its executive team; completed a US$2.3 million capital
investment program in the U.S.; expanded its facility in Rajgurunagar, near
Pune, India; plans US$21 million towards a new clinical supplies facility in
South Wales; and made significant global investments in technology, project
management, and quality standards to help drive customer satisfaction and
success. Other investments include new integrated business processes that
span the entire clinical supply chain and cutting-edge technology solutions
including interactive voice response/interactive web response (IVR/IWR)
services.

“Bilcare has built its reputation on providing customers with the
highest-quality clinical supplies and research services, delivered on time,
every time,” said Mangiardi. “Our new headquarters will allow us to take
our services to the next level while continuing to provide the quality and
attention that customers expect and deserve.”

About Bilcare Global Clinical Supplies
Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with
clinical trial materials support, services, and complete project management.
Its services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical
trial materials (CTM) satisfy a broad range of requirements; from
pre-formulation research and development, manufacturing, analytical services
and clinical supplies packaging and labeling, to IVRS, QP services,
controlled temperature (cold and frozen chain) CTM storage, distribution
worldwide, and returns and destructions accountability.

For more information about Bilcare Global Clinical Supplies, visit
www.BilcareGCS.com.